Mitofusin 2 Deficiency Causes Pro-Inflammatory Effects in Human Primary Macrophages.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2021
Historique:
received: 11 06 2021
accepted: 28 07 2021
entrez: 30 8 2021
pubmed: 31 8 2021
medline: 21 12 2021
Statut: epublish

Résumé

Mitofusin 2 (MFN2) is a mitochondrial outer membrane GTPase, which modulates mitochondrial fusion and affects the interaction between endoplasmic reticulum and mitochondria. Here, we explored how MFN2 influences mitochondrial functions and inflammatory responses towards zymosan in primary human macrophages. A knockdown of MFN2 by small interfering RNA decreased mitochondrial respiration without attenuating mitochondrial membrane potential and reduced interactions between endoplasmic reticulum and mitochondria. A MFN2 deficiency potentiated zymosan-elicited inflammatory responses of human primary macrophages, such as expression and secretion of pro-inflammatory cytokines interleukin-1β, -6, -8 and tumor necrosis factor α, as well as induction of cyclooxygenase 2 and prostaglandin E

Identifiants

pubmed: 34456930
doi: 10.3389/fimmu.2021.723683
pmc: PMC8397414
doi:

Substances chimiques

Cytokines 0
Mitochondrial Proteins 0
Reactive Oxygen Species 0
Mitogen-Activated Protein Kinases EC 2.7.11.24
GTP Phosphohydrolases EC 3.6.1.-
MFN2 protein, human EC 3.6.1.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

723683

Informations de copyright

Copyright © 2021 Khodzhaeva, Schreiber, Geisslinger, Brandes, Brüne and Namgaladze.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Nat Immunol. 2001 Aug;2(8):675-80
pubmed: 11477402
Oncogene. 2007 May 14;26(22):3214-26
pubmed: 17496917
Int Immunol. 2018 Oct 29;30(11):511-528
pubmed: 30165385
J Med Genet. 2010 Apr;47(4):249-56
pubmed: 19889647
Nature. 2001 Jul 19;412(6844):346-51
pubmed: 11460167
J Physiol. 2003 Oct 15;552(Pt 2):335-44
pubmed: 14561818
J Biomed Sci. 2013 Jul 01;20:45
pubmed: 23815800
Nat Genet. 2004 May;36(5):449-51
pubmed: 15064763
Nature. 2008 Dec 4;456(7222):605-10
pubmed: 19052620
J Biol Chem. 2005 Jul 15;280(28):26185-92
pubmed: 15899901
J Cell Biol. 2015 Feb 16;208(4):429-42
pubmed: 25688136
Cell Rep. 2020 Aug 25;32(8):108079
pubmed: 32846136
J Endotoxin Res. 2003;9(3):176-80
pubmed: 12831459
Front Physiol. 2019 May 09;10:517
pubmed: 31156446
Biochem Biophys Res Commun. 2014 Jul 18;450(1):500-6
pubmed: 24928385
Trends Mol Med. 2007 Nov;13(11):460-9
pubmed: 18029230
Blood. 2005 Oct 1;106(7):2543-50
pubmed: 15956283
Am J Physiol Cell Physiol. 2005 Jun;288(6):C1440-50
pubmed: 15647387
J Cell Biol. 2007 Feb 12;176(4):405-14
pubmed: 17296794
Oxid Med Cell Longev. 2014;2014:851692
pubmed: 25147596
Genes Dev. 2001 Nov 15;15(22):2922-33
pubmed: 11711427
Antioxid Redox Signal. 2015 Apr 20;22(12):1020-31
pubmed: 25567790
J Mol Endocrinol. 2017 Feb;58(2):R87-R106
pubmed: 27965371
Sci Signal. 2009 Aug 18;2(84):ra47
pubmed: 19690333
Nature. 2008 Jan 31;451(7178):573-7
pubmed: 18200010
J Biol Chem. 2001 Jun 8;276(23):20781-7
pubmed: 11259437
J Cell Biol. 2003 Jan 20;160(2):189-200
pubmed: 12527753
Nat Commun. 2020 Jan 3;11(1):102
pubmed: 31900386
Expert Rev Hematol. 2017 Jan;10(1):65-79
pubmed: 27911100
J Vis Exp. 2016 Dec 10;(118):
pubmed: 28060261
J Biol Chem. 2006 Mar 3;281(9):5506-14
pubmed: 16407295
Nat Commun. 2019 Jul 29;10(1):3390
pubmed: 31358769
Immunol Res. 2008;42(1-3):3-18
pubmed: 18626576
Nature. 2011 Apr 28;472(7344):476-80
pubmed: 21525932
Oncogene. 1999 Nov 22;18(49):6867-74
pubmed: 10602462
Proc Natl Acad Sci U S A. 2000 Dec 5;97(25):13766-71
pubmed: 11095740
Proc Natl Acad Sci U S A. 2012 Apr 3;109(14):5523-8
pubmed: 22427360
Cardiovasc Res. 2006 Jul 15;71(2):310-21
pubmed: 16581043
Br J Cancer. 2003 May 19;88(10):1598-604
pubmed: 12771929
Annu Rev Pharmacol Toxicol. 2018 Jan 6;58:353-389
pubmed: 28961065
Cancer Res. 2003 Jul 1;63(13):3632-6
pubmed: 12839952
Proc Natl Acad Sci U S A. 2013 Sep 17;110(38):15247-52
pubmed: 23986494
Acta Biochim Biophys Sin (Shanghai). 2015 Jun;47(6):441-50
pubmed: 25926139
Essays Biochem. 2018 Jul 20;62(3):341-360
pubmed: 30030364
Ann Neurol. 2006 Feb;59(2):276-81
pubmed: 16437557
J Biol Chem. 2004 Nov 5;279(45):46384-92
pubmed: 15319438
Antioxid Redox Signal. 2015 Apr 20;22(12):995-1019
pubmed: 25557408
Nature. 1999 Mar 18;398(6724):252-6
pubmed: 10094049
Science. 2015 Dec 4;350(6265):aad2459
pubmed: 26785495
Trends Biochem Sci. 2000 May;25(5):215-21
pubmed: 10782088
Proc Natl Acad Sci U S A. 2013 Oct 29;110(44):17963-8
pubmed: 24127597
EMBO J. 2016 Aug 1;35(15):1677-93
pubmed: 27334614
J Cell Sci. 2004 Dec 15;117(Pt 26):6535-46
pubmed: 15572413
Nat Immunol. 2020 Oct;21(10):1219-1231
pubmed: 32778760
Nature. 2006 Oct 19;443(7113):787-95
pubmed: 17051205
Cancer Immunol Immunother. 2021 Feb;70(2):547-561
pubmed: 32860527
FASEB J. 2020 Mar;34(3):3932-3942
pubmed: 31944406
Curr Biol. 2006 Jul 25;16(14):R551-60
pubmed: 16860735
Nat Rev Mol Cell Biol. 2010 Dec;11(12):872-84
pubmed: 21102612
Physiol Rev. 2002 Jan;82(1):47-95
pubmed: 11773609
Science. 2013 Apr 26;340(6131):471-5
pubmed: 23620051
Proc Natl Acad Sci U S A. 2016 Oct 4;113(40):11249-11254
pubmed: 27647893
J Leukoc Biol. 2011 Sep;90(3):599-611
pubmed: 21653233
Proc Natl Acad Sci U S A. 2005 Dec 6;102(49):17717-22
pubmed: 16301520
Biochim Biophys Acta Mol Cell Biol Lipids. 2018 Apr;1863(4):433-446
pubmed: 29360568
Semin Immunol. 2004 Feb;16(1):3-9
pubmed: 14751757
Cell. 2005 Feb 25;120(4):483-95
pubmed: 15734681
J Immunol. 2003 Jul 1;171(1):417-25
pubmed: 12817025
J Exp Med. 2003 May 5;197(9):1107-17
pubmed: 12719479
Diabetes. 2005 Sep;54(9):2685-93
pubmed: 16123358
Biochim Biophys Acta. 2014 Apr 4;1841(4):595-609
pubmed: 24316057
J Biol Chem. 2003 May 9;278(19):17190-7
pubmed: 12598526
J Immunol. 2010 May 15;184(10):5545-52
pubmed: 20400701
Mol Cell Biol. 2011 Mar;31(6):1309-28
pubmed: 21245373

Auteurs

Vera Khodzhaeva (V)

Institute of Biochemistry I, Faculty of Medicine, Goethe-University Frankfurt, Frankfurt, Germany.

Yannick Schreiber (Y)

Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Frankfurt, Germany.

Gerd Geisslinger (G)

Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Frankfurt, Germany.
Institute of Clinical Pharmacology, Pharmazentrum Frankfurt/ZAFES, University Hospital, Goethe-University Frankfurt, Frankfurt, Germany.

Ralf P Brandes (RP)

Institute for Cardiovascular Physiology, Goethe-University Frankfurt, Frankfurt, Germany.

Bernhard Brüne (B)

Institute of Biochemistry I, Faculty of Medicine, Goethe-University Frankfurt, Frankfurt, Germany.
Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Frankfurt, Germany.
German Cancer Consortium (DKTK), Partner Site Frankfurt, Frankfurt, Germany.
Frankfurt Cancer Institute, Goethe-University Frankfurt, Frankfurt, Germany.

Dmitry Namgaladze (D)

Institute of Biochemistry I, Faculty of Medicine, Goethe-University Frankfurt, Frankfurt, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH